Susie Lisa | CFA, Senior Vice President of Investor Relations |
Reshma Kewalramani | President & Chief Executive Officer |
Stuart Arbuckle | Executive Vice President & Chief Operating Officer |
Charlie Wagner | Executive Vice President & Chief Financial Officer |
Phil Nadeau | Cowen & Company |
Liisa Bayko | Evercore ISI |
Salveen Richter | Goldman Sachs |
Geoff Meacham | Bank of America |
Robyn Karnauskas | Truist Securities |
David Risinger | Leerink Partners |
Terence Flynn | Morgan Stanley |
Mohit Bansal | Wells Fargo |
Michael Yee | Jefferies |
Evan Seigerman | BMO Capital Markets |
Colin Bristow | UBS |
Good afternoon and welcome to the Vertex Pharmaceuticals Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over to Susie Lisa, Senior Vice President, Investor Relations. Please go ahead.
Good evening, everyone.